Clinical Trial Update: Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating lamotrigine for reversing cognitive impairment in chronic corticosteroid-treated patients; the study has completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hippocampal Atrophy Due to Corticosteroid
• Hypomania Due to Corticosteroid Use
• Memory Impairment Due to Corticosteroid Use

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Memory Impairment Due to Corticosteroid Use, Hypomania Due to Corticosteroid Use | Phase 4 | Status: COMPLETED | Results posted: 2019-04-16